We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

54 hedge funds and large institutions have $90.5M invested in Vigil Neuroscience in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

17% more funds holding

Funds holding: 46 → 54 (+8)

7% more capital invested

Capital invested by funds: $84.6M → $90.5M (+$5.99M)

2.16% more ownership

Funds ownership: 69.73% → 71.89% (+2.2%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

33% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 15

Holders
54
Holders Change
+8
Holders Change %
+17.39%
% of All Funds
0.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
10
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$3.73M
2
6CM
683 Capital Management
New York
+$3.11M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$297K
4
Renaissance Technologies
Renaissance Technologies
New York
+$187K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$104K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$700K
2
DM
Deerfield Management
New York
-$603K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$435K
4
Morgan Stanley
Morgan Stanley
New York
-$270K
5
BCM
Bridgeway Capital Management
Texas
-$234K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$19.9M – – –
NV
2
Northpond Ventures
Maryland
$14.4M – – –
Citadel Advisors
3
Citadel Advisors
Florida
$7.39M +$12.2K +3,909 +0.2%
BI
4
BVF Inc
California
$6.18M – – –
AG
5
Artal Group
Luxembourg
$6.18M – – –
SFM
6
Sphera Funds Management
Israel
$5.9M +$3.73M +1,195,294 +223%
DTC
7
Deep Track Capital
Connecticut
$5.44M – – –
6CM
8
683 Capital Management
New York
$3.39M +$3.11M +994,900 New
DM
9
Deerfield Management
New York
$3.34M -$603K -193,212 -16%
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.05M +$297K +95,276 +12%
BlackRock
11
BlackRock
New York
$2.99M -$131K -42,100 -5%
PBPIA
12
Pivotal bioVenture Partners Investment Advisor
California
$1.91M – – –
RSCM
13
Rock Springs Capital Management
Maryland
$1.61M – – –
O
14
OrbiMed
New York
$1.53M – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.14M +$58.4K +18,704 +6%
ACH
16
ArrowMark Colorado Holdings
Colorado
$987K – – –
State Street
17
State Street
Massachusetts
$975K +$8.65K +2,772 +1%
Ensign Peak Advisors
18
Ensign Peak Advisors
Utah
$780K – – –
Northern Trust
19
Northern Trust
Illinois
$473K -$8.37K -2,681 -2%
Barclays
20
Barclays
United Kingdom
$385K -$33.6K -10,759 -9%
DCM
21
DAFNA Capital Management
California
$245K – – –
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$235K +$104K +33,368 New
Citigroup
23
Citigroup
New York
$230K +$2.05K +658 +1%
Renaissance Technologies
24
Renaissance Technologies
New York
$204K +$187K +59,964 New
BCM
25
Bridgeway Capital Management
Texas
$198K -$234K -75,000 -56%
1
2 3

VIGL Hedge Fund Activity: Q1 2024 in Review

54 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q1 2024, worth a combined $90.5M — up 7.1% from $84.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new VIGL positions and 3 closed out — a net gain of 9 holders — while 10 added to existing stakes and 15 trimmed.

The largest buyer was Sphera Funds Management, adding an estimated $3.73M. The largest seller was Anson Funds Management, exiting entirely with an estimated $700K sold.

  • 54 institutional investors held Vigil Neuroscience (VIGL) as of Q1 2024, up from 46 in Q4 2023.
  • Funds reported $90.5M of Vigil Neuroscience stock for Q1 2024, up 7.1% quarter-over-quarter.
  • 12 funds opened new Vigil Neuroscience positions in Q1 2024 and 3 closed out, a net change of +9 holders.
  • The largest Vigil Neuroscience buyer in Q1 2024 was Sphera Funds Management, an estimated $3.73M added.
  • The largest Vigil Neuroscience seller in Q1 2024 was Anson Funds Management, an estimated $700K sold.

Based on aggregated 13F filings for Q1 2024.